The Effect of Naloxone and Cyproheptadine on Pulmonary Platelet Trapping, Hypotension, and Platelet Aggregability in Traumatized Dogs
- 1 May 1983
- journal article
- research article
- Published by Wolters Kluwer Health
- Vol. 23 (5) , 405-407
- https://doi.org/10.1097/00005373-198305000-00008
Abstract
Adult respiratory distress syndrome (ARDS) is a serious complication of trauma and sepsis. Naloxone, an opiate antagonist, and cyproheptadine, an antiserotonin drug, are effective in reducing pulmonary platelet trapping (PPT), which is thought to play an important role in the evolution of ARDS in endotoxin-shocked dogs. Endorphins are implicated as pathophysiologic factors in shock, and serotonin is a possible mediator of their action. Here, naloxone and cyproheptadine are shown to be equally effective in protecting against PPT in dogs subjected to trauma, and when naloxone is given before the trauma it also obviates the hypotension associated with trauma. Naloxone- and cyprohetadine-treated animals did not show the increased platelet aggregability usually seen in traumatized dogs.This publication has 4 references indexed in Scilit:
- Pulmonary Response of Massive Steroids in Seriously Injured PatientsAnnals of Surgery, 1981
- PRESSOR EFFECT OF NALOXONE IN SEPTIC SHOCKThe Lancet, 1981
- Systemic administration of beta-endorphin: potent hypotensive effect involving a serotonergic pathway.Proceedings of the National Academy of Sciences, 1978
- Central cardiovascular effects of morphinomimetic peptides in dogsEuropean Journal of Pharmacology, 1977